Substance type moderates the longitudinal association between depression and substance use from pre-treatment through a 1-year follow-up
- 5 February 2019
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 197, 87-94
Abstract
No abstract availableKeywords
Funding Information
- NIDA
- National Institute on Drug Abuse (R01DA026424)
This publication has 51 references indexed in Scilit:
- Opioid receptors: distinct roles in mood disordersTrends in Neurosciences, 2013
- An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment programDrug and Alcohol Dependence, 2011
- A Comparison of Independent Depression and Substance-Induced Depression in Cannabis-, Cocaine-, and Opioid-Dependent Treatment SeekersThe American Journal on Addictions, 2011
- Withdrawal symptoms in abstinent methamphetamine‐dependent subjectsAddiction, 2010
- Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.Pharmacology Biochemistry and Behavior, 2010
- The effects of binge drinking on college students' next‐day academic test‐taking performance and mood stateAddiction, 2010
- Stress-related factors in cannabis use and misuse: Implications for prevention and treatmentJournal of Substance Abuse Treatment, 2009
- Perceived discrimination and health: A meta-analytic review.Psychological Bulletin, 2009
- Adults seeking treatment for marijuana dependence: A comparison with cocaine-dependent treatment seekers.Experimental and Clinical Psychopharmacology, 1998
- Nocturnal and next‐day effects of ethanol and basal level of sleepinessHuman Psychopharmacology: Clinical and Experimental, 1991